ABBV901
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV901, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer [Phase 1]